Ana P Teixeira
Overview
Explore the profile of Ana P Teixeira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Teixeira A, Franko N, Fussenegger M
Biotechnol Bioeng
. 2025 Jan;
122(4):1051-1061.
PMID: 39801452
Human pluripotent stem cells (hPSCs) can be differentiated in vitro to an increasing number of mature cell types, presenting significant promise for addressing a wide range of diseases and studying...
2.
Galvan S, Teixeira A, Fussenegger M
Biotechnol Bioeng
. 2024 Jun;
121(10):2987-3000.
PMID: 38867466
Synthetic biology aims to contribute to the development of next-generation patient-specific cell-based therapies for chronic diseases especially through the construction of sophisticated synthetic gene switches to enhance the safety and...
3.
Teixeira A, Fussenegger M
Adv Sci (Weinh)
. 2023 Dec;
11(8):e2309088.
PMID: 38126677
Arming human cells with synthetic gene circuits enables to expand their capacity to execute superior sensing and response actions, offering tremendous potential for innovative cellular therapeutics. This can be achieved...
4.
Teixeira A, Haddad Jr W, Barreto L, Secaf A, Mermejo L, Lucchesi F, et al.
Radiol Bras
. 2023 May;
56(2):59-66.
PMID: 37168042
Objective: To assess the diagnostic accuracy of histogram analysis on unenhanced computed tomography (CT) for differentiating between adrenal adenomas and pheochromocytomas (PCCs). Materials And Methods: We retrospectively identified patients with...
5.
Galvan S, Madderson O, Xue S, Teixeira A, Fussenegger M
Adv Sci (Weinh)
. 2022 Oct;
9(34):e2203193.
PMID: 36316222
Next-generation gene and engineered-cell therapies benefit from incorporating synthetic gene networks that can precisely regulate the therapeutic output in response to externally administered signal inputs that are safe, readily bioavailable...
6.
Dias M, Vidigal J, Sequeira D, Alves P, Teixeira A, Roldao A
G3 (Bethesda)
. 2022 Mar;
12(4).
PMID: 35288739
No abstract available.
7.
Teixeira A, Stucheli P, Auslander S, Auslander D, Schonenberger P, Hurlemann S, et al.
Metab Eng
. 2022 Jan;
70:23-30.
PMID: 35007751
Current protocols for generating stable transgenic cell lines mostly rely on antibiotic selection or the use of specialized cell lines lacking an essential part of their metabolic machinery, but these...
8.
Stefanov B, Teixeira A, Mansouri M, Bertschi A, Krawczyk K, Hamri G, et al.
Adv Sci (Weinh)
. 2021 Sep;
8(21):e2101813.
PMID: 34496151
Body temperature is maintained at around 37 °C in humans, but may rise to 40 °C or more during high-grade fever, which occurs in most adults who are seriously ill....
9.
Dias M, Vidigal J, Sequeira D, Alves P, Teixeira A, Roldao A
G3 (Bethesda)
. 2021 May;
11(8).
PMID: 33982066
Insect Trichoplusia ni High Five™ (Hi5) cells have been widely explored for production of heterologous proteins, traditionally mostly using the lytic baculovirus expression vector system (BEVS), and more recently using...
10.
Fernandes B, Vidigal J, Correia R, Carrondo M, Alves P, Teixeira A, et al.
J Biotechnol
. 2019 Nov;
307:139-147.
PMID: 31697977
Adaptive laboratory evolution (ALE) has been extensively used to modulate the phenotype of industrial model organisms (e.g. Escherichia. coli and Saccharomyces cerevisae) towards a specific trait. Nevertheless, its application to...